Analyst Ratings For Cytori Therapeutics (NASDAQ:CYTX)
Today, Cytori Therapeutics (NASDAQ:CYTX) stock was downgraded by B. Riley from Buy to Neutral with a price target of $5.75.
There are 1 hold rating, 1 buy rating on the stock.
The current consensus rating on Cytori Therapeutics (NASDAQ:CYTX) is Buy (Score: 2.50) with a consensus target price of $7.88 per share, a potential 1,540.97% upside.
Some recent analyst ratings include
- 7/25/2017-B. Riley was Downgraded by analysts at B. Riley from a “Buy ” rating to a ” Neutral” rating. They now have a $5.75 price target on the stock.
- 6/28/2016-Roth Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For Cytori Therapeutics (NASDAQ:CYTX)
Cytori Therapeutics (NASDAQ:CYTX) has insider ownership of 2.60% and institutional ownership of 8.65%.
- On 8/10/2016 John David Harris, VP, bought 2,500 with an average share price of $2.03 per share and the total transaction amounting to $5,075.00. View SEC Filing
- On 6/14/2016 Gail K Naughton, Director, bought 1,000 with an average share price of $2.10 per share and the total transaction amounting to $2,100.00. View SEC Filing
- On 5/13/2016 John David Harris, VP, bought 2,000 with an average share price of $2.71 per share and the total transaction amounting to $5,420.00. View SEC Filing
- On 3/9/2016 David Rickey, Director, bought 150,000 with an average share price of $0.19 per share and the total transaction amounting to $28,500.00. View SEC Filing
- On 9/3/2015 Tommy G Thompson, Director, bought 25,449 with an average share price of $0.37 per share and the total transaction amounting to $9,416.13. View SEC Filing
- On 9/2/2015 Jeremy B Hayden, VP, bought 8,200 with an average share price of $0.36 per share and the total transaction amounting to $2,952.00. View SEC Filing
- On 8/28/2015 David Rickey, Director, bought 56,000 with an average share price of $0.31 per share and the total transaction amounting to $17,360.00. View SEC Filing
Recent Trading Activity for Cytori Therapeutics (NASDAQ:CYTX)
Shares of Cytori Therapeutics closed the previous trading session at 0.480 0.000 0.00% with 7,464,054 shares trading hands.